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INTRODUCTION
From work carried out largely by Alain
Prochiantz and his co-workers at the
College de France (Sugiyama et al., 2008;
Beurdeley et al., 2012; Carlier et al., 2013;
Smythies and Edelstein, 2013; Spatazza
et al., 2013a,b), it is now known that the
homeoprotein and transcription factor
molecule Otx2 possesses a very unusual
property. This flexible molecule is able
to cross cell membranes without using
a specific energy-requiring carrier. The
entry mechanism involves organizing a
micelle structure out of the planar lipopro-
tein plasma membrane via interactions
between charged residues and lipophilic
interactions. This micelle carries the
molecule of Otx2 across the membrane.
It has been shown that the membrane
exit mechanism of a related molecule,
Engrailed 2, is different and involves the
formation of energy-dependent calveoli-
like vesicles (Sugiyama et al., 2008; Carlier
et al., 2013; Spatazza et al., 2013a). These
vesicles are delivered into the interior of
the cell.
When injected into the eye Otx2 is
transported to the visual cortex where
it enters PV-expressing GABAergic INs
(PVs), which it activates (Sugiyama et al.,
2008; Beurdeley et al., 2012; Carlier et al.,
2013; Spatazza et al., 2013a,b). During
natural development, following the open-
ing of the eyes, Otx2 molecules accumu-
late “gradually” in the visual cortex. In
vivo, the molecule at source is synthesized
in a retinal bipolar cell and transmit-
ted to a retinal ganglion cell. The gan-
glion cell contains no Otx2 mRNA. At
the other end of the journey, neither does
the cortical cell; its Otx2 is transmitted
from neurons in the lateral geniculate
nucleus (LGN).
AXONAL TRANSPORT
Molecules are usually carried along axons
by one of two mechanisms (Kaether et al.,
2000; Roy, 2013). Individual proteins,
bundled into packets called multiprotein
complexes, are carried by the slow system.
This moves at a speed of less than 0.8 cm a
day. Vesicles, on the other hand, are carried
by the fast system at speeds of up to 20 cm
a day. The distance between the retina and
the visual cortex in mice is about 1 cm.
Thus amolecule taking the fast route could
make the journey in about 1 h, whereas
the minimum time for a molecule taking
the slow route would be about 24 h—not
allowing for the time needed to cross two
synapses. The time that an Otx2 molecule
takes to get from the retina to the cortex
is 24 h (Prochiantz, personal communi-
cation). The rate of build-up would also
depend on the amount of the molecule
bring transmitted and the rate of diffusion
at the target. Presumably, Otx2 would use
one of these axonal transport mechanisms
during its travel along axons, as it is dif-
ficult to visualize it wriggling on its own
along axons from one cell to the next for
these long distances.
THE REST OF THE JOURNEY
Here we present three hypotheses (that are
not necessarily mutually exclusive—that is
to say the molecule of Otx2 could use dif-
ferent mechanisms for different parts of its
journey).
HYPOTHESIS 1
It could cross each intervening membrane
on its ownwithout any carrier mechanism,
by the molecular mechanism as described
above. It could also cross the synaptic cleft
by itself via the cytoplasm, nanotubules
Marzo et al., 2012; Fuxe et al., 2013; Kinney
et al., 2013, or via perisynaptic astrocytes
(Smythies and Edelstein, 2013). Sugiyama
et al. (2008) have shown that it can cross
the plasma membrane of the target PVs,
since cortical infusion over 5 days results
in robust Otx2 signaling throughout the
visual cortex. But how does the molecule
of Otx2 avoid false trails on its sojourn?
This may be answered by what we call
an “All roads lead to Rome” hypothesis.
Since the Otx2 molecule is carrying no
other information other than that the eye
is being stimulated, then a diffuse pro-
jection might prove sufficient. The Otx2
molecule could take any path from the
retina to the cortex, so long as it was along
a visual axon. The diffuse scattering of
Otx2 molecules in the LGN reported by
Sugiyama et al. (2008) may support this.
These authors say “In the LGN, Otx2 pro-
tein was diffusely spread overmultiple cells
unlike Otx2 transcripts found within dis-
crete GABAergic interneurons.” Another
objection is that this model would seem
to need an inordinate number of specific
cell recognition lipo/sugar sites on the sur-
face of all the membranes it has to cross
en route to its target. Furthermore, these
recognition sites are only located on the
surface of PV neurons (Beurdeley et al.,
2012; Spatazza et al., 2013a,b). However, if
it is fed into a transport system that is more
or less sealed from its surroundings (i.e.,
the optic nerve and optic radiation) where
there is a great deal of anterograde traffic,
perhaps it is swept along by the flood?
HYPOTHESIS 2
Otx2 could use a mechanism similar
to that employed by botulinum toxin
(Akaike et al., 2013). Botulinum neurotox-
ins (NTXs) are transported both antero-
and retrogradely along either motor or
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sensory axons for bidirectional delivery
in the central nervous system. This mode
of travel involves the recycling of synap-
tic vesicles. A newly developed type of
NTX, A2 NTX (A2NTX), injected into
one rat foreleg muscle, was transported to
the contralateral muscle. This finding indi-
cates that the NTX traveled retrogradely
via spinal neurons and then transsynapti-
cally through motor neurons to the con-
tralateral motor neurons within the spinal
cord, and then anterogradely to the soleus
muscle (Akaike et al., 2013). Following
BoNT-A injection into the rat eye, sig-
nificant levels of BoNT-A-cleaved SNAP-
25 appeared in the superior colliculus
(Restani et al., 2011).
HYPOTHESIS 3
Otx2 could use the exosome system in a
variety of ways. Exosomes are lipoprotein
vesicles given off by nearly all cells and
are used to exchange epigenetic material,
such as protein transcription factors and a
variety of RNAs (Smythies and Edelstein,
2013). They are constructed inside mul-
tivesicular bodies (MVBs) located, in the
case of neurons, at the axon terminal of
a pre-synaptic neuron A. Here, a complex
mechanism in which RNA-induced silenc-
ing complexes (RISC) may be involved
(Pegtel et al., 2011, p. 15), loads them
with very specific mixtures of epigenetic
molecules. The loaded exosomes are then
transported to the plasma membrane,
which they cross, and are further trans-
ported across the synapse, most likely via
astrocytes and nanotubules (Marzo et al.,
2012; Fuxe et al., 2013; Kinney et al., 2013),
to be delivered to the interior of the post-
synaptic neuron B. At this point, some
release their cargoes locally, while others
are transported to the perinuclear zone
where they discharge their payloads in
order to modulate transcription (Smythies
and Edelstein, 2013). We will discuss what
may happen to these latter vesicles them-
selves later.
In this account, however, we have
noticed that something appears to bemiss-
ing. Where do the proteins and nucleic
acids that are loaded into the exosome
come from? We have not yet seen this
specific question addressed in the litera-
ture. The state of our knowledge on this
subject was put recently by Vlassov et al.
(2012) as “The packaging of specific cargo
loads with appropriate destination tags
itself is extremely intriguing and currently
a black box . . . .” This process is mod-
ulated by heparanase (Thompson et al.,
2013) and tetraspanins (Perez-Hernandez
et al., 2013). As the ingredients of the
cargo presumably do not float in from
the cytoplasm, there seems to be only one
possible source—synthesis by the nucleus
of the pre-synaptic neuron. This would
involve a carrier mechanism to trans-
port them from the perinuclear zone
to the axon terminal. Presumably, this
would consist of specific vesicles, which
we can call pre-exosomes, carried by the
well-established dynein-based fast axonal
transport mechanism.
This raises a rather interesting second
question. Where do these pre-exosomes
come from? The perinuclear zone exports
many differently-specified vesicles to carry
themany different proteins down the axon.
Arepre-exosomesderived fromthis general
pool? Conceivably, however, there may be
another source. As we have seen above, the
perinuclear zone of a post-synaptic neu-
ron B transsynaptically receives exosomes
carrying epigenetic cargoes that originated
from thepre-synaptic neuronA.Therefore,
it seems possible that these exosomes, after
being emptied of their cargo, could be recy-
cled and used as pre-exosomes to transport
new protein and nucleic acid epigenetic
payloads from the nucleus of post-synaptic
neuron B to its own exosome factory in its
own axon terminal that forms a synapse
with post-synaptic neuron C, one neuron
further along the network. Such recycling
of vesicles and their membranes is found
elsewhere in the brain—for example, in
the case of synaptic vesicles where a sin-
gle vesicle may be used hundreds of times.
In the transsynaptic part of the exosome
system itself, exosomes are ferried in both
directions across the synapse (Smalheiser,
2007). Thus, exosomes may not only be
exporting protein transcription factors and
nucleic acids, but quantities of membrane
aswell. Thismembranematerial could pass
down a chain of synaptically-connected
neurons potentially carrying information.
We can use this mechanism to construct
an hypothesis to explain how the unusual
transcription protein Otx2 could act.
Our third hypothesis (of those listed
above) suggests the following mechanism.
The molecule of Otx2 is synthesized in
the bipolar cell in the retina and crosses
into the ganglion cell by the direct trans-
membrane mechanism described above.
It then enters the cytoplasm of the gan-
glion cell inside its calveoli-like vesicle.
This vesicle may then either be directly
loaded onto the fast transport system,
or fused with an already existing pre-
load-bearing exosome, to be pulled by
the dynein motor along the microtubule
track. The contained Otx2 molecule could
also be bundled into a multiprotein com-
plex and carried by the slow route. Since
Otx2 is an epigenetic transcription pro-
tein, and that the pre-exosome is spe-
cialized for the transport of epigenetic
molecules, the Otx2 molecule may possess
the right molecular identification codes to
effect this transmission. This now puts the
Otx2 molecule inside the exosome system
as cargo within a pre-exosome. The pre-
exosome may then be carried down the
ganglion cell axon along the optic nerve
to the MVBs in the axon terminal of the
synapse with an LGN neuron. Here, it
is processed by the mechanism described
above, in which its cargo is delivered, shuf-
fled and reloaded into exosomes. These
cross the synapse and are further trans-
ported to the perinuclear zone of the LGN
neuron. They then release their payloads
and the Otx2 molecules are taken-up by
the second fast axonal transport mecha-
nism, where they are sent on their way to
the next synapse in the chain that the LGN
axon makes with the PV cell. The exo-
some then releases its cargo into the synap-
tic cleft to allow the Otx2 molecules to
bind to the polysaccharide receptors on the
PNNs of the PV target neuron in the man-
ner described by Sugiyama et al. (2008),
Beurdeley et al. (2012) and Spatazza et al.
(2013a,b). However, against this hypothe-
sis is the fact that no homeoproteins have
so far been reported as constituents of
exosome payloads. A place to look for
them might be the pathway from retina
to visual cortex. It is quite possible that
the calveoli-like vesicles described above,
in which Otx2 molecules are delivered
into the lumen of the axon, are treated
as exosomes from that point on but are
not identified as such by current tests and
methodologies.
Continuous accumulation of Otx2 in
PV cells may be necessary to sustain a
state that limits further plasticity in the
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adult (Beurdeley et al., 2012). When this
supply is cut off by deafferentation, and
replaced by an input belonging to another
sensory modality, this may allow the cell
to undergo plastic changes organized per-
haps by a new modality specific homeo-
protein carried by the new input, and by
epigenetic material carried by exosomes
(Smythies and Edelstein, 2013). However,
Sugiyama et al. (2008) have shown that
Otx2 suffused into an immature visual
cortex is sufficient to promote the full
growth and functionality of PV neurons.
Therefore, the full contribution of exo-
some payloads to the epigenetics of the
post-synaptic neuron must be something
other than acting on PV cells in this way.
Epigenetic cortical restructuring involves
many neuronal locations and species other
than PV cells, such as dendrites and spines
(Smythies and Edelstein, 2013). Perhaps
the microRNAs and other chemical con-
stituents transferred by exosomes play a
role in these events. It seems reason-
able to suggest that the abundant and
diverse cargo of epigenetic material carried
by exosomes must have some epigenetic
function in the receiving cell. Hopefully,
experiments can be devised to test these
hypotheses.
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